{
  "paper_id": "PMC6640147",
  "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6640147/",
  "figures": {
    "figure_1": {
      "figure_number": "Figure 1",
      "title": "Figure 1:",
      "caption": "Lifetime cumulative incidence of brain tumors and death in patients with myotonic dystrophy",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec9d/6640147/65757b0fbc7b/nihms-1040314-f0001.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec9d/6640147/65757b0fbc7b/nihms-1040314-f0001.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec9d/6640147/65757b0fbc7b/nihms-1040314-f0001.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec9d/6640147/65757b0fbc7b/nihms-1040314-f0001.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "F1",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec9d/6640147/65757b0fbc7b/nihms-1040314-f0001.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC6640147/images/figure_1.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec9d/6640147/65757b0fbc7b/nihms-1040314-f0001.jpg"
    },
    "figure_2": {
      "figure_number": "Figure 2",
      "title": "Figure 2:",
      "caption": "Survival patterns in myotonic dystrophy patients after brain tumor diagnosis",
      "possible_urls": [
        [
          "original_src",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec9d/6640147/ec6a46d32b84/nihms-1040314-f0002.jpg"
        ],
        [
          "large_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec9d/6640147/ec6a46d32b84/nihms-1040314-f0002.jpg?maxwidth=2000"
        ],
        [
          "original_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec9d/6640147/ec6a46d32b84/nihms-1040314-f0002.jpg?size=original"
        ],
        [
          "xlarge_size",
          "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec9d/6640147/ec6a46d32b84/nihms-1040314-f0002.jpg?maxwidth=4000"
        ]
      ],
      "figure_id": "F2",
      "is_table": false,
      "working_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec9d/6640147/ec6a46d32b84/nihms-1040314-f0002.jpg",
      "download_success": true,
      "local_image_path": "./data/PMC6640147/images/figure_2.jpg",
      "final_url": "https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ec9d/6640147/ec6a46d32b84/nihms-1040314-f0002.jpg"
    }
  },
  "claims": [
    {
      "sentence": "Table 2:\nStandardized incidence ratios of brain tumors in Swedish DM patients\n\n\n\n\n\n\n\n\n\n\nObserved\nExpected\nSIR (95% CI)\nP value\n\n\n\nOverall\n20\n3.7\n5.4 (3.4–8.1\n1×10−5\n\n\n\nAge in years\n\n\n\n\n\n\n 0–19\n1\n0.39\n2.6 (0.1–12.6)\n0.4\n\n\n 20–59\n5\n1.25\n4.0 (1.5–8.9)\n0.01\n\n\n ≥60\n6\n0.68\n8.8 (3.6–18.4)\n8×10−5\n\n\n\nSex\n\n\n\n\n\n\n Male\n11\n1.7\n6.5 (3.4–11.2)\n<1×10−5\n\n\n\n Female\n9\n2.4\n3.8 (1.8–6.9)\n0.001\n\n\nAge at first DM diagnosis\n\n\n\n\n\n\n <20 years\n1\n0.4\n2.5 (0.1–12)\n0.4\n\n\n ≥ 20 years\n19\n3.3\n5.7 (3.5–8.7)\n<1×10−5\n\n\n\n\nOpen in a new tabThe cumulative incidence of brain tumors in DM patients accounting for competing mortality was: 1.3% (95%CI=0.6–2.3%) by age 50 years, 1.9% (95%CI=1.1–3.2%) by age 60, and 2.9% (95%CI=1.8–4.7%) by age 70 (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 1:\n\nOpen in a new tab\nLifetime cumulative incidence of brain tumors and death in patients with myotonic dystrophySurvival patterns after the diagnosis of brain tumor:\nThe 3- and 5-year overall survival probabilities after brain tumor diagnosis in DM patients were: 65% (95% CI= 43–86%), and 52% (95%CI=29–75%), respectively (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Figure 2:\n\nOpen in a new tab\nSurvival patterns in myotonic dystrophy patients after brain tumor diagnosisDISCUSSION\nOur study, based on updated follow-up of a Swedish DM cohort, and including all brain tumors regardless of the date of the first recorded DM clinical diagnosis, confirmed that brain tumors are part of the DM syndrome phenotype.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Table 2:\nStandardized incidence ratios of brain tumors in Swedish DM patients\n\n\n\n\n\n\n\n\n\n\nObserved\nExpected\nSIR (95% CI)\nP value\n\n\n\nOverall\n20\n3.7\n5.4 (3.4–8.1\n1×10−5\n\n\n\nAge in years\n\n\n\n\n\n\n 0–19\n1\n0.39\n2.6 (0.1–12.6)\n0.4\n\n\n 20–59\n5\n1.25\n4.0 (1.5–8.9)\n0.01\n\n\n ≥60\n6\n0.68\n8.8 (3.6–18.4)\n8×10−5\n\n\n\nSex\n\n\n\n\n\n\n Male\n11\n1.7\n6.5 (3.4–11.2)\n<1×10−5\n\n\n\n Female\n9\n2.4\n3.8 (1.8–6.9)\n0.001\n\n\nAge at first DM diagnosis\n\n\n\n\n\n\n <20 years\n1\n0.4\n2.5 (0.1–12)\n0.4\n\n\n ≥ 20 years\n19\n3.3\n5.7 (3.5–8.7)\n<1×10−5\n\n\n\n\nOpen in a new tabThe cumulative incidence of brain tumors in DM patients accounting for competing mortality was: 1.3% (95%CI=0.6–2.3%) by age 50 years, 1.9% (95%CI=1.1–3.2%) by age 60, and 2.9% (95%CI=1.8–4.7%) by age 70 (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 1:\n\nOpen in a new tab\nLifetime cumulative incidence of brain tumors and death in patients with myotonic dystrophySurvival patterns after the diagnosis of brain tumor:\nThe 3- and 5-year overall survival probabilities after brain tumor diagnosis in DM patients were: 65% (95% CI= 43–86%), and 52% (95%CI=29–75%), respectively (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Figure 2:\n\nOpen in a new tab\nSurvival patterns in myotonic dystrophy patients after brain tumor diagnosisDISCUSSION\nOur study, based on updated follow-up of a Swedish DM cohort, and including all brain tumors regardless of the date of the first recorded DM clinical diagnosis, confirmed that brain tumors are part of the DM syndrome phenotype.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Table 2:\nStandardized incidence ratios of brain tumors in Swedish DM patients\n\n\n\n\n\n\n\n\n\n\nObserved\nExpected\nSIR (95% CI)\nP value\n\n\n\nOverall\n20\n3.7\n5.4 (3.4–8.1\n1×10−5\n\n\n\nAge in years\n\n\n\n\n\n\n 0–19\n1\n0.39\n2.6 (0.1–12.6)\n0.4\n\n\n 20–59\n5\n1.25\n4.0 (1.5–8.9)\n0.01\n\n\n ≥60\n6\n0.68\n8.8 (3.6–18.4)\n8×10−5\n\n\n\nSex\n\n\n\n\n\n\n Male\n11\n1.7\n6.5 (3.4–11.2)\n<1×10−5\n\n\n\n Female\n9\n2.4\n3.8 (1.8–6.9)\n0.001\n\n\nAge at first DM diagnosis\n\n\n\n\n\n\n <20 years\n1\n0.4\n2.5 (0.1–12)\n0.4\n\n\n ≥ 20 years\n19\n3.3\n5.7 (3.5–8.7)\n<1×10−5\n\n\n\n\nOpen in a new tabThe cumulative incidence of brain tumors in DM patients accounting for competing mortality was: 1.3% (95%CI=0.6–2.3%) by age 50 years, 1.9% (95%CI=1.1–3.2%) by age 60, and 2.9% (95%CI=1.8–4.7%) by age 70 (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 1:\n\nOpen in a new tab\nLifetime cumulative incidence of brain tumors and death in patients with myotonic dystrophySurvival patterns after the diagnosis of brain tumor:\nThe 3- and 5-year overall survival probabilities after brain tumor diagnosis in DM patients were: 65% (95% CI= 43–86%), and 52% (95%CI=29–75%), respectively (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Figure 2:\n\nOpen in a new tab\nSurvival patterns in myotonic dystrophy patients after brain tumor diagnosisDISCUSSION\nOur study, based on updated follow-up of a Swedish DM cohort, and including all brain tumors regardless of the date of the first recorded DM clinical diagnosis, confirmed that brain tumors are part of the DM syndrome phenotype.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Table 2:\nStandardized incidence ratios of brain tumors in Swedish DM patients\n\n\n\n\n\n\n\n\n\n\nObserved\nExpected\nSIR (95% CI)\nP value\n\n\n\nOverall\n20\n3.7\n5.4 (3.4–8.1\n1×10−5\n\n\n\nAge in years\n\n\n\n\n\n\n 0–19\n1\n0.39\n2.6 (0.1–12.6)\n0.4\n\n\n 20–59\n5\n1.25\n4.0 (1.5–8.9)\n0.01\n\n\n ≥60\n6\n0.68\n8.8 (3.6–18.4)\n8×10−5\n\n\n\nSex\n\n\n\n\n\n\n Male\n11\n1.7\n6.5 (3.4–11.2)\n<1×10−5\n\n\n\n Female\n9\n2.4\n3.8 (1.8–6.9)\n0.001\n\n\nAge at first DM diagnosis\n\n\n\n\n\n\n <20 years\n1\n0.4\n2.5 (0.1–12)\n0.4\n\n\n ≥ 20 years\n19\n3.3\n5.7 (3.5–8.7)\n<1×10−5\n\n\n\n\nOpen in a new tabThe cumulative incidence of brain tumors in DM patients accounting for competing mortality was: 1.3% (95%CI=0.6–2.3%) by age 50 years, 1.9% (95%CI=1.1–3.2%) by age 60, and 2.9% (95%CI=1.8–4.7%) by age 70 (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 1:\n\nOpen in a new tab\nLifetime cumulative incidence of brain tumors and death in patients with myotonic dystrophySurvival patterns after the diagnosis of brain tumor:\nThe 3- and 5-year overall survival probabilities after brain tumor diagnosis in DM patients were: 65% (95% CI= 43–86%), and 52% (95%CI=29–75%), respectively (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Figure 2:\n\nOpen in a new tab\nSurvival patterns in myotonic dystrophy patients after brain tumor diagnosisDISCUSSION\nOur study, based on updated follow-up of a Swedish DM cohort, and including all brain tumors regardless of the date of the first recorded DM clinical diagnosis, confirmed that brain tumors are part of the DM syndrome phenotype.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Table 2:\nStandardized incidence ratios of brain tumors in Swedish DM patients\n\n\n\n\n\n\n\n\n\n\nObserved\nExpected\nSIR (95% CI)\nP value\n\n\n\nOverall\n20\n3.7\n5.4 (3.4–8.1\n1×10−5\n\n\n\nAge in years\n\n\n\n\n\n\n 0–19\n1\n0.39\n2.6 (0.1–12.6)\n0.4\n\n\n 20–59\n5\n1.25\n4.0 (1.5–8.9)\n0.01\n\n\n ≥60\n6\n0.68\n8.8 (3.6–18.4)\n8×10−5\n\n\n\nSex\n\n\n\n\n\n\n Male\n11\n1.7\n6.5 (3.4–11.2)\n<1×10−5\n\n\n\n Female\n9\n2.4\n3.8 (1.8–6.9)\n0.001\n\n\nAge at first DM diagnosis\n\n\n\n\n\n\n <20 years\n1\n0.4\n2.5 (0.1–12)\n0.4\n\n\n ≥ 20 years\n19\n3.3\n5.7 (3.5–8.7)\n<1×10−5\n\n\n\n\nOpen in a new tabThe cumulative incidence of brain tumors in DM patients accounting for competing mortality was: 1.3% (95%CI=0.6–2.3%) by age 50 years, 1.9% (95%CI=1.1–3.2%) by age 60, and 2.9% (95%CI=1.8–4.7%) by age 70 (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 1:\n\nOpen in a new tab\nLifetime cumulative incidence of brain tumors and death in patients with myotonic dystrophySurvival patterns after the diagnosis of brain tumor:\nThe 3- and 5-year overall survival probabilities after brain tumor diagnosis in DM patients were: 65% (95% CI= 43–86%), and 52% (95%CI=29–75%), respectively (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Figure 2:\n\nOpen in a new tab\nSurvival patterns in myotonic dystrophy patients after brain tumor diagnosisDISCUSSION\nOur study, based on updated follow-up of a Swedish DM cohort, and including all brain tumors regardless of the date of the first recorded DM clinical diagnosis, confirmed that brain tumors are part of the DM syndrome phenotype.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Table 2:\nStandardized incidence ratios of brain tumors in Swedish DM patients\n\n\n\n\n\n\n\n\n\n\nObserved\nExpected\nSIR (95% CI)\nP value\n\n\n\nOverall\n20\n3.7\n5.4 (3.4–8.1\n1×10−5\n\n\n\nAge in years\n\n\n\n\n\n\n 0–19\n1\n0.39\n2.6 (0.1–12.6)\n0.4\n\n\n 20–59\n5\n1.25\n4.0 (1.5–8.9)\n0.01\n\n\n ≥60\n6\n0.68\n8.8 (3.6–18.4)\n8×10−5\n\n\n\nSex\n\n\n\n\n\n\n Male\n11\n1.7\n6.5 (3.4–11.2)\n<1×10−5\n\n\n\n Female\n9\n2.4\n3.8 (1.8–6.9)\n0.001\n\n\nAge at first DM diagnosis\n\n\n\n\n\n\n <20 years\n1\n0.4\n2.5 (0.1–12)\n0.4\n\n\n ≥ 20 years\n19\n3.3\n5.7 (3.5–8.7)\n<1×10−5\n\n\n\n\nOpen in a new tabThe cumulative incidence of brain tumors in DM patients accounting for competing mortality was: 1.3% (95%CI=0.6–2.3%) by age 50 years, 1.9% (95%CI=1.1–3.2%) by age 60, and 2.9% (95%CI=1.8–4.7%) by age 70 (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 1:\n\nOpen in a new tab\nLifetime cumulative incidence of brain tumors and death in patients with myotonic dystrophySurvival patterns after the diagnosis of brain tumor:\nThe 3- and 5-year overall survival probabilities after brain tumor diagnosis in DM patients were: 65% (95% CI= 43–86%), and 52% (95%CI=29–75%), respectively (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Figure 2:\n\nOpen in a new tab\nSurvival patterns in myotonic dystrophy patients after brain tumor diagnosisDISCUSSION\nOur study, based on updated follow-up of a Swedish DM cohort, and including all brain tumors regardless of the date of the first recorded DM clinical diagnosis, confirmed that brain tumors are part of the DM syndrome phenotype.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Table 2:\nStandardized incidence ratios of brain tumors in Swedish DM patients\n\n\n\n\n\n\n\n\n\n\nObserved\nExpected\nSIR (95% CI)\nP value\n\n\n\nOverall\n20\n3.7\n5.4 (3.4–8.1\n1×10−5\n\n\n\nAge in years\n\n\n\n\n\n\n 0–19\n1\n0.39\n2.6 (0.1–12.6)\n0.4\n\n\n 20–59\n5\n1.25\n4.0 (1.5–8.9)\n0.01\n\n\n ≥60\n6\n0.68\n8.8 (3.6–18.4)\n8×10−5\n\n\n\nSex\n\n\n\n\n\n\n Male\n11\n1.7\n6.5 (3.4–11.2)\n<1×10−5\n\n\n\n Female\n9\n2.4\n3.8 (1.8–6.9)\n0.001\n\n\nAge at first DM diagnosis\n\n\n\n\n\n\n <20 years\n1\n0.4\n2.5 (0.1–12)\n0.4\n\n\n ≥ 20 years\n19\n3.3\n5.7 (3.5–8.7)\n<1×10−5\n\n\n\n\nOpen in a new tabThe cumulative incidence of brain tumors in DM patients accounting for competing mortality was: 1.3% (95%CI=0.6–2.3%) by age 50 years, 1.9% (95%CI=1.1–3.2%) by age 60, and 2.9% (95%CI=1.8–4.7%) by age 70 (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 1:\n\nOpen in a new tab\nLifetime cumulative incidence of brain tumors and death in patients with myotonic dystrophySurvival patterns after the diagnosis of brain tumor:\nThe 3- and 5-year overall survival probabilities after brain tumor diagnosis in DM patients were: 65% (95% CI= 43–86%), and 52% (95%CI=29–75%), respectively (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Figure 2:\n\nOpen in a new tab\nSurvival patterns in myotonic dystrophy patients after brain tumor diagnosisDISCUSSION\nOur study, based on updated follow-up of a Swedish DM cohort, and including all brain tumors regardless of the date of the first recorded DM clinical diagnosis, confirmed that brain tumors are part of the DM syndrome phenotype.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Table 2:\nStandardized incidence ratios of brain tumors in Swedish DM patients\n\n\n\n\n\n\n\n\n\n\nObserved\nExpected\nSIR (95% CI)\nP value\n\n\n\nOverall\n20\n3.7\n5.4 (3.4–8.1\n1×10−5\n\n\n\nAge in years\n\n\n\n\n\n\n 0–19\n1\n0.39\n2.6 (0.1–12.6)\n0.4\n\n\n 20–59\n5\n1.25\n4.0 (1.5–8.9)\n0.01\n\n\n ≥60\n6\n0.68\n8.8 (3.6–18.4)\n8×10−5\n\n\n\nSex\n\n\n\n\n\n\n Male\n11\n1.7\n6.5 (3.4–11.2)\n<1×10−5\n\n\n\n Female\n9\n2.4\n3.8 (1.8–6.9)\n0.001\n\n\nAge at first DM diagnosis\n\n\n\n\n\n\n <20 years\n1\n0.4\n2.5 (0.1–12)\n0.4\n\n\n ≥ 20 years\n19\n3.3\n5.7 (3.5–8.7)\n<1×10−5\n\n\n\n\nOpen in a new tabThe cumulative incidence of brain tumors in DM patients accounting for competing mortality was: 1.3% (95%CI=0.6–2.3%) by age 50 years, 1.9% (95%CI=1.1–3.2%) by age 60, and 2.9% (95%CI=1.8–4.7%) by age 70 (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 1:\n\nOpen in a new tab\nLifetime cumulative incidence of brain tumors and death in patients with myotonic dystrophySurvival patterns after the diagnosis of brain tumor:\nThe 3- and 5-year overall survival probabilities after brain tumor diagnosis in DM patients were: 65% (95% CI= 43–86%), and 52% (95%CI=29–75%), respectively (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Figure 2:\n\nOpen in a new tab\nSurvival patterns in myotonic dystrophy patients after brain tumor diagnosisDISCUSSION\nOur study, based on updated follow-up of a Swedish DM cohort, and including all brain tumors regardless of the date of the first recorded DM clinical diagnosis, confirmed that brain tumors are part of the DM syndrome phenotype.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Table 2:\nStandardized incidence ratios of brain tumors in Swedish DM patients\n\n\n\n\n\n\n\n\n\n\nObserved\nExpected\nSIR (95% CI)\nP value\n\n\n\nOverall\n20\n3.7\n5.4 (3.4–8.1\n1×10−5\n\n\n\nAge in years\n\n\n\n\n\n\n 0–19\n1\n0.39\n2.6 (0.1–12.6)\n0.4\n\n\n 20–59\n5\n1.25\n4.0 (1.5–8.9)\n0.01\n\n\n ≥60\n6\n0.68\n8.8 (3.6–18.4)\n8×10−5\n\n\n\nSex\n\n\n\n\n\n\n Male\n11\n1.7\n6.5 (3.4–11.2)\n<1×10−5\n\n\n\n Female\n9\n2.4\n3.8 (1.8–6.9)\n0.001\n\n\nAge at first DM diagnosis\n\n\n\n\n\n\n <20 years\n1\n0.4\n2.5 (0.1–12)\n0.4\n\n\n ≥ 20 years\n19\n3.3\n5.7 (3.5–8.7)\n<1×10−5\n\n\n\n\nOpen in a new tabThe cumulative incidence of brain tumors in DM patients accounting for competing mortality was: 1.3% (95%CI=0.6–2.3%) by age 50 years, 1.9% (95%CI=1.1–3.2%) by age 60, and 2.9% (95%CI=1.8–4.7%) by age 70 (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 1:\n\nOpen in a new tab\nLifetime cumulative incidence of brain tumors and death in patients with myotonic dystrophySurvival patterns after the diagnosis of brain tumor:\nThe 3- and 5-year overall survival probabilities after brain tumor diagnosis in DM patients were: 65% (95% CI= 43–86%), and 52% (95%CI=29–75%), respectively (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Figure 2:\n\nOpen in a new tab\nSurvival patterns in myotonic dystrophy patients after brain tumor diagnosis.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Table 2:\nStandardized incidence ratios of brain tumors in Swedish DM patients\n\n\n\n\n\n\n\n\n\n\nObserved\nExpected\nSIR (95% CI)\nP value\n\n\n\nOverall\n20\n3.7\n5.4 (3.4–8.1\n1×10−5\n\n\n\nAge in years\n\n\n\n\n\n\n 0–19\n1\n0.39\n2.6 (0.1–12.6)\n0.4\n\n\n 20–59\n5\n1.25\n4.0 (1.5–8.9)\n0.01\n\n\n ≥60\n6\n0.68\n8.8 (3.6–18.4)\n8×10−5\n\n\n\nSex\n\n\n\n\n\n\n Male\n11\n1.7\n6.5 (3.4–11.2)\n<1×10−5\n\n\n\n Female\n9\n2.4\n3.8 (1.8–6.9)\n0.001\n\n\nAge at first DM diagnosis\n\n\n\n\n\n\n <20 years\n1\n0.4\n2.5 (0.1–12)\n0.4\n\n\n ≥ 20 years\n19\n3.3\n5.7 (3.5–8.7)\n<1×10−5\n\n\n\n\nOpen in a new tabThe cumulative incidence of brain tumors in DM patients accounting for competing mortality was: 1.3% (95%CI=0.6–2.3%) by age 50 years, 1.9% (95%CI=1.1–3.2%) by age 60, and 2.9% (95%CI=1.8–4.7%) by age 70 (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Figure 1:\n\nOpen in a new tab\nLifetime cumulative incidence of brain tumors and death in patients with myotonic dystrophy.",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "The cumulative incidence of brain tumors in DM patients accounting for competing mortality was: 1.3% (95%CI=0.6–2.3%) by age 50 years, 1.9% (95%CI=1.1–3.2%) by age 60, and 2.9% (95%CI=1.8–4.7%) by age 70 (Figure 1).",
      "figure_references": [
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        },
        {
          "figure_number": "Figure 1",
          "panel": "",
          "figure_key": "figure_1"
        }
      ]
    },
    {
      "sentence": "Survival patterns after the diagnosis of brain tumor:\nThe 3- and 5-year overall survival probabilities after brain tumor diagnosis in DM patients were: 65% (95% CI= 43–86%), and 52% (95%CI=29–75%), respectively (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "Figure 2:\n\nOpen in a new tab\nSurvival patterns in myotonic dystrophy patients after brain tumor diagnosis.",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    },
    {
      "sentence": "The 3- and 5-year overall survival probabilities after brain tumor diagnosis in DM patients were: 65% (95% CI= 43–86%), and 52% (95%CI=29–75%), respectively (Figure 2).",
      "figure_references": [
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        },
        {
          "figure_number": "Figure 2",
          "panel": "",
          "figure_key": "figure_2"
        }
      ]
    }
  ],
  "extraction_stats": {
    "figures_count": 2,
    "claims_count": 33,
    "images_downloaded": 2,
    "tables_filtered": 35
  }
}